IQVIA Holdings (IQV) revenue

Revenue · fiscal 2025
$16.31B

IQVIA Holdings (IQV) reported revenue of $16.31B in fiscal 2025 (the year ended December 31, 2025). That is 5.9% higher than the $15.41B of fiscal 2024. Figures as of 18 Nov 2026, 09:54 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$16.31B
Change on fiscal 2024
+5.9%
Growth, 5 years
+7.5% a year
Growth, 10 years
+11.0% a year
Highest on record
$16.31Bfiscal 2025
Lowest on record
$4.33Bfiscal 2011
Fiscal years on record
152011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

IQVIA Holdings revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 7.5% a year; over ten years the rate was 11.0% a year. Across the 15 fiscal years on record (2011–2025), the highest was $16.31B in fiscal 2025 and the lowest $4.33B in fiscal 2011.

History · 15 fiscal years

Revenue by fiscal year

IQVIA Holdings revenue, year by year

IQVIA Holdings (IQV) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$16.31B 5.9% up
2024$15.41B 2.8% up
2023$14.98B 4.0% up
2022$14.41B 3.9% up
2021$13.87B 22.1% up
2020$11.36B 2.4% up
2019$11.09B 6.5% up
2018$10.41B 7.3% up
2017$9.70B 42.4% up
2016$6.82B 18.8% up
2015$5.74B 5.1% up
2014$5.46B 7.1% up
2013$5.10B 4.8% up
2012$4.87B 12.4% up
2011$4.33B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of IQVIA Holdings and comparable companies
CompanyRevenueFiscal year
Teva Pharmaceutical Industries TEVA$17.26B2025
BeOne Medicines ONC$5.34B2025
Waters WAT$3.17B2025
Natera NTRA$2.31B2025
IQVIA Holdings IQV$16.31B2025
Revolution Medicines RVMD$11.58M2023

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on IQV

IQVIA Holdings, figure by figure

IQVIA Holdings (IQV) overview: price, valuation and scorecardAll health care companies by market value

IQVIA Holdings revenue: questions and answers

What is IQVIA Holdings's revenue?

IQVIA Holdings (IQV) reported revenue of $16.31B in fiscal 2025 (the year ended December 31, 2025). That is 5.9% higher than the $15.41B of fiscal 2024.

What is the growth rate of IQVIA Holdings's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 7.5% a year; over ten years the rate was 11.0% a year.

What are the highest and lowest revenue figures on record for IQVIA Holdings?

Across the 15 fiscal years on record (2011–2025), the highest was $16.31B in fiscal 2025 and the lowest $4.33B in fiscal 2011.

How is IQVIA Holdings's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For IQVIA Holdings it is on record here for 15 fiscal years, 2011 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “IQVIA Holdings (IQV) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/IQV/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.